Astex Pharmaceuticals - Company & Market Research Reports

Astex Pharmaceuticals is a member of one of Japan's leading pharmaceutical companies, the Otsuka group. It focuses on developing small-molecule therapeutics with a focus on oncology and hematology. Its fragment-based drug discovery platform, Pyramid, has been successfully applied to therapeutic targets addressing a variety of disease areas. The company was formerly known as SuperGen Inc. and changed its name in September 2011. Astex was founded in 1991 and is headquartered in Dublin, California.

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Oncology Drug Discovery Services Market, 2017-2030 - Product Thumbnail Image

Oncology Drug Discovery Services Market, 2017-2030

  • Report
  • 270 Pages
From
The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 265 Pages
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Gamma Secretase Inhibitor -Pipeline Insight, 2018 - Product Thumbnail Image

Gamma Secretase Inhibitor -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Myelodysplastic Syndrome - Pipeline Review, H1 2018 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1006 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) - Pipeline Review, H2 201 - Product Thumbnail Image

Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) - Pipeline Review, H2 201

  • Drug Pipelines
  • 56 Pages
From
Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2018 - Product Thumbnail Image

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 43 Pages
From
HIV / AIDS - Pipeline Review, H1 2015 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2015

  • Drug Pipelines
  • 871 Pages
From
Global Cancer CDK Inhibitors Market & Clinical Pipeline Outlook 2022 - Product Thumbnail Image

Global Cancer CDK Inhibitors Market & Clinical Pipeline Outlook 2022

  • Report
  • 150 Pages
From
DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026 - Product Thumbnail Image

DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026

  • Report
  • 284 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

  • Drug Pipelines
  • 515 Pages
From
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends and Pipeline Analysis) - Product Thumbnail Image

Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends and Pipeline Analysis)

  • Report
  • 232 Pages
From
Hematological Tumor - Pipeline Review, H1 2014 - Product Thumbnail Image

Hematological Tumor - Pipeline Review, H1 2014

  • Drug Pipelines
  • 450 Pages
From
Rho-Associated Protein Kinase 1 (Renal Carcinoma Antigen NY-REN-35 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 1 or p160 ROCK-1 or EC 2.7.11.1) - Pipeline Review, H1 2016 - Product Thumbnail Image

Rho-Associated Protein Kinase 1 (Renal Carcinoma Antigen NY-REN-35 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 1 or p160 ROCK-1 or EC 2.7.11.1) - Pipeline Review, H1 2016

  • Drug Pipelines
  • 36 Pages
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 1827 Pages
From
Alzheimer s: Epidemiology Overview and Insights - Product Thumbnail Image

Alzheimer s: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Loading Indicator
adroll